Search
for
Sort by
Research 61–90 of 166
- Cutaneous Manifestations of Lupus Erythematosus
- Drug-Induced Skin, Nail and Hair Disorders
- Dermatologic Adverse Events from Cancer Treatments
- Clinical manifestations of cutaneous lupus erythematosus
- Adverse Cutaneous Reactions to Mood Stabilizers
- Severe and Fatal Phenobarbitone Eruptions
- Persistent Panniculitis in Dermatomyositis
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Cutaneous manifestations of COVID-19: a case report and review of the literature
- Medications
- Cutaneous manifestations of systemic infection in children
- Dermatological adverse events with taxane chemotherapy
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Anticonvulsant-Induced Cutaneous Reactions
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- The clinical spectrum of parathyroid disease
- Severe cardiac conduction abnormalities associated with atypical toxic shock syndrome
- Dermatologic Care of the Transplant Patient
- Dermatological Drugs, Topical Agents, and Cosmetics
- Cutaneous drug reactions
- Insights About a Pandemic: Clinical Approach
- Clin-Alert
- Vacuum Therapy in Association with Plant ActiveCompounds, Prebiotics and Probiotics for Treatment ofAndrogenetic Alopecia, Female Pattern Hair Loss andTelogen Effluvium, Part II: Follow-up Study
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Mucocutaneous reactions to chemotherapy
- Tinea Capitis: An Overview with Emphasis on Management
- Graft-versus-host disease
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Adverse Cutaneous Reactions to Antidepressants